Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutationsJaewon Choi, Vikram R. Juneja, Jared L. Dietze et al.|Cell Reports Methods|2021Cited by 65
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trialJessica S.W. Borgers, Marit M. van Buuren, Divya Lenkala et al.|Nature Medicine|2025Cited by 40